ZYXI - Zynex Inc Stock Price, Fair Value and News

8.95USD-1.24 (-12.17%)Market Closed

Market Summary

USD8.95-1.24

Market Closed

-12.17%

ZYXI Alerts

Big fall in earnings (Y/Y)

ZYXI Stock Price

View Fullscreen

ZYXI RSI Chart

ZYXI Valuation

Market Cap

283.9M

Price/Earnings (Trailing)

47.04

Price/Sales (Trailing)

1.47

EV/EBITDA

32.09

Price/Free Cashflow

16.53

ZYXI Price/Sales (Trailing)

ZYXI Profitability

EBT Margin

4.39%

Return on Equity

18.39%

Return on Assets

4.95%

Free Cashflow Yield

6.05%

ZYXI Fundamentals

ZYXI Revenue

Revenue (TTM)

193.6M

Rev. Growth (Yr)

10.97%

Rev. Growth (Qtr)

7.2%

ZYXI Earnings

Earnings (TTM)

6.0M

Earnings Growth (Yr)

-63.71%

Earnings Growth (Qtr)

12.1K%

Breaking Down ZYXI Revenue

Last 7 days

-11.4%

Last 30 days

0.2%

Last 90 days

-20.2%

Trailing 12 Months

-8.2%

How does ZYXI drawdown profile look like?

ZYXI Financial Health

Current Ratio

4.06

Debt/Equity

1.77

Debt/Cashflow

0.31

ZYXI Investor Care

Buy Backs (1Y)

11.91%

Diluted EPS (TTM)

0.18

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	188.7M	193.6M	0	0
2023	169.3M	177.4M	185.8M	184.3M
2022	137.3M	143.0M	149.7M	158.2M
2021	89.0M	100.8M	115.5M	130.3M
2020	51.5M	60.5M	68.7M	80.1M
2019	34.2M	37.0M	40.6M	45.5M
2018	26.9M	29.4M	30.7M	31.9M
2017	13.3M	15.0M	18.2M	23.4M
2016	11.9M	12.1M	13.1M	13.3M
2015	11.1M	12.9M	11.1M	11.6M
2014	17.2M	13.1M	12.3M	11.1M
2013	38.4M	33.9M	29.0M	21.7M
2012	36.5M	38.1M	38.8M	39.7M
2011	26.6M	29.1M	31.6M	34.1M
2010	0	0	0	24.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About Zynex Inc

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

CEO	Mr. Thomas Sandgaard
WEBSITE	zynex.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	900

Zynex Inc Frequently Asked Questions

What is the ticker symbol for Zynex Inc? What does ZYXI stand for in stocks?

ZYXI is the stock ticker symbol of Zynex Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Zynex Inc (ZYXI)?

As of Fri Jul 26 2024, market cap of Zynex Inc is 283.95 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ZYXI stock?

You can check ZYXI's fair value in chart for subscribers.

Is Zynex Inc a good stock to buy?

The fair value guage provides a quick view whether ZYXI is over valued or under valued. Whether Zynex Inc is cheap or expensive depends on the assumptions which impact Zynex Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ZYXI.

What is Zynex Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, ZYXI's PE ratio (Price to Earnings) is 47.04 and Price to Sales (PS) ratio is 1.47. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZYXI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Zynex Inc's stock?

In the past 10 years, Zynex Inc has provided 0.44 (multiply by 100 for percentage) rate of return.